SS Innovations International, Inc.

SSIINASDAQHealthcare● Active

$3.53

$-0.25(-6.61%)

Market Cap$706464319

P/E Ratio—

52W High$11.87

52W Low$3.015

Avg Volume56K

Open$3.88

Beta0.68

Free Cash Flow Financials Revenue

SS Innovations International, Inc. (SSII) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

SSII · free cash flow · updated Jun 8, 2026

Core FCF metrics

SSII · FCF · TTM · margin & CAGR

Free cash flow was −$22.2M for FY2025 (fiscal year ending 2025-12-31), down 118.4% year-over-year The FCF margin was -52.3%.

FY2025 Free Cash Flow−$22.2M▼ -118.4% YoY

Trailing 12M (TTM)−$17.6Mtrailing 4 quarters sum

FCF Margin-52.3%−$22.2M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

SSII · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$18.5M(4M)−$22.2M▼ 118.4%-52.3%

FY2024−$9.5M(1M)−$10.2M▲ +35.7%-49.2%

FY2023−$15.4M(0M)−$15.8M▼ 1001.4%-269.0%

FY2022−$6.0M(5M)−$1.4M▼ 295.5%-98.5%

FY2021−$363,034(0M)−$363,034▼ 284.0%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

SSII · P/FCF · FCF yield · FCF per share

SS Innovations International, Inc. (SSII) reported negative free cash flow of −$0.02B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

SSII · cash flow statement · operating / investing / financing

For FY2025, SS Innovations International, Inc. generated −$18.5M in operating cash flow and spent 4M in capital expenditures, yielding −$22.2M in free cash flow.

Operating Activities

−$18.5M

Cash from core business operations

2025-12-31

Investing Activities

−$3.7M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$26.2M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$18.5M) − |CapEx| (4M) = FCF (−$22.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

SSII vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

SS Innovations International, Inc.YOU

SSII

−$22.2M-118.4%-52.3%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

SS Innovations International, Inc. (SSII) reported free cash flow of −$22.2M for FY2025 (fiscal year ending 2025-12-31), down 118.4% year-over-year. The FCF margin was -52.3%.

SS Innovations International, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 10 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

SSII free cash flow · 8 questions

SS Innovations International, Inc. free cash flow was −$22.2M for FY2025, down 118.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$17.6M.

SSII free cash flowSSII FCFSSII FCF 2025SSII free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · SS Innovations International, Inc. · SS Innovations International, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026